Ads
related to: lenalidomide rituximab follicular lymphoma- Dosing & Administration
Download The EPKINLY™
Dosing & Administration Guide.
- Prescribing Information
Access Prescribing Info Including
Boxed Warnings for EPKINLY™.
- FDA-Approved Treatment
Learn About EPKINLY™ and
Access HCP Resources.
- Clinical Trial Results
See How EPKINLY™ Performed
in Clinical Trials.
- Contact A Representative
Connect With A Representative
To Learn More About EPKINLY™.
- Register For Updates
Sign Up For EPKINLY™
News, Clinical Data Updates & More.
- Dosing & Administration
careinfo.mayoclinic.org has been visited by 100K+ users in the past month
Search results
Results From The WOW.Com Content Network
In situ follicular lymphoma is an accumulation of monoclonal B cells (i.e. cells descendent from a single ancestral cell) in the germinal centers of lymphoid tissue. These cells commonly bear a pathological genomic abnormality, i.e. a translocation between position 32 on the long (i.e. "q") arm of chromosome 14 and position 21 on chromosome 18's q arm.
Rituximab, sold under the brand name Rituxan among others, is a monoclonal antibody medication used to treat certain autoimmune diseases and types of cancer. [18] It is used for non-Hodgkin lymphoma, chronic lymphocytic leukemia (in children and adults, but not recommended in elderly patients), rheumatoid arthritis, granulomatosis with polyangiitis, idiopathic thrombocytopenic purpura ...
Non-Hodgkin's lymphoma and follicular lymphoma. Thrombocytopenia, neutropenia, anaemia, hypotension and secondary malignancies. Ipilimumab: IV: CTLA4 antibody that causes immune system-mediated lysis of the tagged cell: Unresectable or metastatic malignant melanoma. Life-threatening immune mediated reactions and fever. Nivolumab: IV
Lenalidomide, sold under the brand name Revlimid among others, is a medication used to treat multiple myeloma, smoldering myeloma, and myelodysplastic syndromes (MDS). [8] For multiple myeloma, it is a first line treatment, and is given with dexamethasone . [ 8 ]
non-Hodgkin lymphoma: RdC lenalidomide (Revlimid), dexamethasone, cyclophosphamide: AL amyloidosis R-Benda rituximab + bendamustine: follicular lymphoma and MALT lymphoma [7] R-DHAP or DHAP-R: rituximab + DHAP; that is, rituximab, dexamethasone (a steroid hormone), cytarabine (ara-C), platinum agent: relapsed non-Hodgkin's lymphoma and Hodgkin ...
For premium support please call: 800-290-4726 more ways to reach us
Ads
related to: lenalidomide rituximab follicular lymphoma